Castleview Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-30
Closed -$11.2K 708
2024
Q2
$11.2K Sell
30
-3,268
-99% -$1.1M 0.01% 502
2024
Q1
$1.14M Buy
3,298
+3,277
+15,605% +$1.24M 0.64% 31
2023
Q4
$9.61K Sell
21
-4
-16% -$1.97K 0.01% 516
2023
Q3
$12.2K Hold
25
0.01% 407
2023
Q2
$11.2K Hold
25
0.01% 421
2023
Q1
$12.1K Hold
25
0.01% 403
2022
Q4
$12.8K Hold
25
0.01% 336
2022
Q3
$12K Sell
25
-729
-97% -$355K 0.01% 361
2022
Q2
$119K Buy
754
+729
+2,916% +$324K 0.09% 193
2022
Q1
$10K Sell
25
-25,951
-100% -$10.9M 0.01% 497
2021
Q4
$56 Buy
+25,976
New +$11.5M ﹤0.01% 873

Other funds holding HUM

Castleview Partners's HUM Position: Q3 2024 in Review

Castleview Partners sold out of Humana (HUM) in Q3 2024, closing a stake of 30 shares — an estimated $11.2K sold.

Castleview Partners first reported a position in HUM in Q4 2021 and held it in 11 quarters. The position peaked at $1.14M in Q1 2024. 940 funds tracked by Wall St. Rank hold HUM as of Q3 2024.

  • Castleview Partners reported no remaining Humana position as of Q3 2024 after selling out during the quarter.
  • Castleview Partners sold 30 Humana shares in Q3 2024, an estimated $11.2K.
  • Castleview Partners first reported a position in Humana in Q4 2021 and held it in 11 quarters.
  • Castleview Partners's Humana position peaked at $1.14M in Q1 2024.
  • 940 funds tracked by Wall St. Rank held Humana as of Q3 2024.

Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.